Pui-Kai Li, PhD

College

College of Pharmacy

Academic Title

Assoc Professor

Research Program

Molecular Carcinogenesis and Chemoprevention

Research Interest

Cancer, Breast Cancer, Prostatic Cancer, Glioblastoma, Osteosarcoma, Amnesia

The research area of Dr. Li focuses in the design, synthesis and biochemical testing of steroidal and non-steroidal steroid sulfatase inhibitors as potential agents for the treatment of hormone-dependent cancers.

Education and Background

Office Location

338 Parks Hall

500 W 12th Avenue, Columbus, Ohio 43210

614-688-0253

614-292-2435

li.27@osu.edu

Publications

Novel pyrrolopyrimidines as Mps1/TTK kinase inhibitors for breast cancer.

Sugimoto Y, Sawant DB, Fisk HA, Mao L, Li C, Chettiar S, Li PK, Darby MV, Brueggemeier RW

Bioorg Med Chem 25 2156-2166 04/01/2017
Niclosamide and its analogs are potent inhibitors of Wnt/ß-catenin, mTOR and STAT3 signaling in ovarian cancer.

Arend RC, Londoño-Joshi AI, Gangrade A, Katre AA, Kurpad C, Li Y, Samant RS, Li PK, Landen CN, Yang ES, Hidalgo B, Alvarez RD, Straughn JM, Forero A, Buchsbaum DJ, Arend RC, Londoño-Joshi AI, Gangrade A, Katre AA, Kurpad C, Li Y, Samant RS, Li PK, Landen CN, Yang ES, Hidalgo B, Alvarez RD, Straughn JM, Forero A, Buchsbaum DJ

Oncotarget 7 86803-86815 12/27/2016
Niclosamide and its analogs are potent inhibitors of Wnt/ß-catenin, mTOR and STAT3 signaling in ovarian cancer.

Arend RC, Londoño-Joshi AI, Gangrade A, Katre AA, Kurpad C, Li Y, Samant RS, Li PK, Landen CN, Yang ES, Hidalgo B, Alvarez RD, Straughn JM, Forero A, Buchsbaum DJ, Arend RC, Londoño-Joshi AI, Gangrade A, Katre AA, Kurpad C, Li Y, Samant RS, Li PK, Landen CN, Yang ES, Hidalgo B, Alvarez RD, Straughn JM, Forero A, Buchsbaum DJ

Oncotarget 7 86803-86815 12/27/2016
STAT3 as a potential therapeutic target in ALDH+ and CD44+/CD24+ stem cell-like pancreatic cancer cells.

Lin L, Jou D, Wang Y, Ma H, Liu T, Fuchs J, Li PK, Lü J, Li C, Lin J

Int J Oncol 49 2265-2274 12/01/2016
Protective effect of suppressing STAT3 activity in LPS-induced acute lung injury.

Zhao J, Yu H, Liu Y, Gibson SA, Yan Z, Xu X, Gaggar A, Li PK, Li C, Wei S, Benveniste EN, Qin H

Am J Physiol Lung Cell Mol Physiol 311 L868-L880 11/01/2016
Niclosamide Analogs for Treatment of Ovarian Cancer.

Walters Haygood CL, Arend RC, Gangrade A, Li PK, Hidalgo B, Straughn JM Jr, Buchsbaum DJ, Walters Haygood CL, Arend RC, Gangrade A, Chettiar S, Regan N, Hassmann CJ 2nd, Li PK, Hidalgo B, Straughn JM Jr, Buchsbaum DJ

Int J Gynecol Cancer 25 1377-85 10/01/2015
Niclosamide Analogs for Treatment of Ovarian Cancer.

Walters Haygood CL, Arend RC, Gangrade A, Li PK, Hidalgo B, Straughn JM Jr, Buchsbaum DJ, Walters Haygood CL, Arend RC, Gangrade A, Chettiar S, Regan N, Hassmann CJ 2nd, Li PK, Hidalgo B, Straughn JM Jr, Buchsbaum DJ

Int J Gynecol Cancer 25 1377-85 10/01/2015
Multi-targeted therapy of cancer by niclosamide: A new application for an old drug.

Li Y, Li PK, Roberts MJ, Arend RC, Samant RS, Buchsbaum DJ

Cancer Lett 349 8-14 07/10/2014
Tumor-induced STAT3 signaling in myeloid cells impairs dendritic cell generation by decreasing PKCßII abundance.

Farren MR, Carlson LM, Netherby CS, Lindner I, Li PK, Gabrilovich DI, Abrams SI, Lee KP

Sci Signal 7 ra16 02/18/2014
Structure-activity relationship studies of thalidomide analogs with a taxol-like mode of action.

Pandit B, Hu Z, Chettiar SN, Zink J, Xiao Z, Etter JP, Bhasin D, Li PK

Bioorg Med Chem Lett 23 6902-4 12/15/2013
Antiproliferative activities and SAR studies of substituted anthraquinones and 1,4-naphthoquinones.

Bhasin D, Etter JP, Chettiar SN, Mok M, Li PK

Bioorg Med Chem Lett 23 6864-7 12/15/2013
Phosphoproteomic analysis of anaplastic lymphoma kinase (ALK) downstream signaling pathways identifies signal transducer and activator of transcription 3 as a functional target of activated ALK in neuroblastoma cells.

Sattu K, Hochgräfe F, Wu J, Umapathy G, Schönherr C, Ruuth K, Chand D, Witek B, Fuchs J, Li PK, Hugosson F, Daly RJ, Palmer RH, Hallberg B

FEBS J 280 5269-82 11/01/2013
Design, synthesis and biological studies of survivin dimerization modulators that prolong mitotic cycle.

Chettiar SN, Cooley JV, Park IH, Bhasin D, Chakravarti A, Li PK, Li C, Jacob NK

Bioorg Med Chem Lett 23 5429-33 10/01/2013
JAK-STAT blockade inhibits tumor initiation and clonogenic recovery of prostate cancer stem-like cells.

Kroon P, Berry PA, Stower MJ, Rodrigues G, Mann VM, Simms M, Bhasin D, Chettiar S, Li C, Li PK, Maitland NJ, Collins AT

Cancer Res 73 5288-98 08/15/2013
Design, synthesis and biological studies of novel tubulin inhibitors.

Sun Y, Pandit B, Chettiar SN, Etter JP, Lewis A, Johnsamuel J, Li PK

Bioorg Med Chem Lett 23 4465-8 08/01/2013
Anticancer activity and SAR studies of substituted 1,4-naphthoquinones.

Bhasin D, Chettiar SN, Etter JP, Mok M, Li PK

Bioorg Med Chem 21 4662-9 08/01/2013
Inhibition of human ?-glutamyl transpeptidase: development of more potent, physiologically relevant, uncompetitive inhibitors.

Wickham S, Regan N, West MB, Thai J, Cook PF, Terzyan SS, Li PK, Hanigan MH

Biochem J 450 547-57 03/15/2013
Evaluation of STAT3 signaling in ALDH+ and ALDH+/CD44+/CD24- subpopulations of breast cancer cells.

Lin L, Hutzen B, Lee HF, Peng Z, Wang W, Zhao C, Lin HJ, Sun D, Li PK, Li C, Korkaya H, Wicha MS, Lin J

PLoS One 8 e82821 01/01/2013
The effect of the steroid sulfatase inhibitor (p-O-sulfamoyl)-tetradecanoyl tyramine (DU-14) on learning and memory in rats with selective lesion of septal-hippocampal cholinergic tract.

Babalola PA, Fitz NF, Gibbs RB, Flaherty PT, Li PK, Johnson DA

Neurobiol Learn Mem 98 303-10 10/01/2012
First-in-human trial of a STAT3 decoy oligonucleotide in head and neck tumors: implications for cancer therapy.

Sen M, Thomas SM, Kim S, Yeh JI, Ferris RL, Johnson JT, Duvvuri U, Lee J, Sahu N, Joyce S, Freilino ML, Shi H, Li C, Ly D, Rapireddy S, Etter JP, Li PK, Wang L, Chiosea S, Seethala RR, Gooding WE, Chen X, Kaminski N, Pandit K, Johnson DE, Grandis JR

Cancer Discov 2 694-705 08/01/2012
Divergent effects of compounds on the hydrolysis and transpeptidation reactions of ?-glutamyl transpeptidase.

Wickham S, Regan N, West MB, Kumar VP, Thai J, Li PK, Cook PF, Hanigan MH

J Enzyme Inhib Med Chem 27 476-89 08/01/2012

See Full List

Back to Researcher Search

Find a Researcher
Find a Clinical Trial

Please enter a keyword (i.e. Name, Research Interest) or choose a Research Program

By Name or Keyword

OR

By Research Program

Please enter a keyword (i.e. Name, Cancer Type) or choose a Principle Investigator

Pui-Kai Li, PhD

College

Academic Title

Research Program

Research Interest

Education and Background

Office Location

Publications

Novel pyrrolopyrimidines as Mps1/TTK kinase inhibitors for breast cancer.

Niclosamide and its analogs are potent inhibitors of Wnt/ß-catenin, mTOR and STAT3 signaling in ovarian cancer.

Niclosamide and its analogs are potent inhibitors of Wnt/ß-catenin, mTOR and STAT3 signaling in ovarian cancer.

STAT3 as a potential therapeutic target in ALDH+ and CD44+/CD24+ stem cell-like pancreatic cancer cells.

Protective effect of suppressing STAT3 activity in LPS-induced acute lung injury.

Niclosamide Analogs for Treatment of Ovarian Cancer.

Niclosamide Analogs for Treatment of Ovarian Cancer.

Multi-targeted therapy of cancer by niclosamide: A new application for an old drug.

Tumor-induced STAT3 signaling in myeloid cells impairs dendritic cell generation by decreasing PKCßII abundance.

Structure-activity relationship studies of thalidomide analogs with a taxol-like mode of action.

Antiproliferative activities and SAR studies of substituted anthraquinones and 1,4-naphthoquinones.

Phosphoproteomic analysis of anaplastic lymphoma kinase (ALK) downstream signaling pathways identifies signal transducer and activator of transcription 3 as a functional target of activated ALK in neuroblastoma cells.

Design, synthesis and biological studies of survivin dimerization modulators that prolong mitotic cycle.

JAK-STAT blockade inhibits tumor initiation and clonogenic recovery of prostate cancer stem-like cells.

Design, synthesis and biological studies of novel tubulin inhibitors.

Anticancer activity and SAR studies of substituted 1,4-naphthoquinones.

Inhibition of human ?-glutamyl transpeptidase: development of more potent, physiologically relevant, uncompetitive inhibitors.

Evaluation of STAT3 signaling in ALDH+ and ALDH+/CD44+/CD24- subpopulations of breast cancer cells.

The effect of the steroid sulfatase inhibitor (p-O-sulfamoyl)-tetradecanoyl tyramine (DU-14) on learning and memory in rats with selective lesion of septal-hippocampal cholinergic tract.

First-in-human trial of a STAT3 decoy oligonucleotide in head and neck tumors: implications for cancer therapy.

Divergent effects of compounds on the hydrolysis and transpeptidation reactions of ?-glutamyl transpeptidase.

OR

OR

Search for Clinical Trials

Find a Scientific Publication

Pui-Kai Li, PhD

College

Academic Title

Research Program

Research Interest

Education and Background

Office Location

Publications

Related Links

OR

OR

Search for Clinical Trials

Find a Scientific Publication